The Lancet | Pan-cancer prediction of radiotherapy benefit with genomic-adjusted radiation dose @TheLancetTV | Uploaded August 2021 | Updated October 2024, 1 hour ago.
Authors Jacob Scott and Javier Torres-Roca discuss their study, Pan-cancer prediction of radiotherapy benefit using genomic-adjusted radiation dose (GARD): a cohort-based pooled analysis.

Read the full paper in The Lancet Oncology: thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00347-8/fulltext?dgcid=youtube_video_lanonc

Visit The Lancet Oncology at thelancet.com/journals/lanonc/home?dgcid=youtube_video_lanonc
Find out more at thelancet.com/?dgcid=youtube_video_lancet_lancet

* * *
Continue this conversation on social! Follow us today at…
Twitter.com/TheLancet
facebook.com/TheLancetMedicalJournal
LinkedIn.com/company/the-lancet